Free Trial

XTX Topco Ltd Invests $2.43 Million in The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Key Points

  • XTX Topco Ltd has acquired a new stake in The Clorox Company, purchasing 16,494 shares valued at approximately $2,429,000.
  • Several institutional investors have also increased their positions in Clorox, with a total of 78.53% of the company's stock now held by institutional investors.
  • Clorox's recent quarterly earnings report showed a miss on earnings per share at $1.45, falling short of the consensus estimate of $1.57, with a revenue decrease of 8.0% year-over-year.
  • Need better tools to track Clorox? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

XTX Topco Ltd acquired a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the first quarter, according to its most recent disclosure with the SEC. The firm acquired 16,494 shares of the company's stock, valued at approximately $2,429,000.

A number of other hedge funds also recently added to or reduced their stakes in CLX. Redwood Park Advisors LLC acquired a new stake in Clorox during the 4th quarter worth approximately $26,000. Wood Tarver Financial Group LLC acquired a new stake in Clorox during the 4th quarter worth approximately $31,000. GKV Capital Management Co. Inc. purchased a new position in shares of Clorox during the 4th quarter worth approximately $32,000. Aster Capital Management DIFC Ltd purchased a new position in shares of Clorox during the 4th quarter worth approximately $33,000. Finally, GW&K Investment Management LLC raised its stake in shares of Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after buying an additional 208 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on CLX. Citigroup reissued a "neutral" rating and set a $135.00 target price (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. UBS Group cut their target price on Clorox from $150.00 to $134.00 and set a "neutral" rating for the company in a research note on Thursday, July 17th. Evercore ISI set a $140.00 target price on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Wells Fargo & Company increased their target price on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a research note on Friday. Finally, Jefferies Financial Group cut their target price on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Three analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company's stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $143.36.

Check Out Our Latest Stock Analysis on Clorox

Clorox Price Performance

NYSE CLX traded down $2.50 during mid-day trading on Friday, hitting $123.06. The stock had a trading volume of 3,928,421 shares, compared to its average volume of 1,666,065. The Clorox Company has a 52-week low of $117.35 and a 52-week high of $171.37. The company has a market cap of $15.17 billion, a price-to-earnings ratio of 18.87, a P/E/G ratio of 3.46 and a beta of 0.49. The company has a 50 day simple moving average of $126.07 and a 200 day simple moving average of $139.01. The company has a quick ratio of 0.44, a current ratio of 0.74 and a debt-to-equity ratio of 13.07.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The firm had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.94 billion. Clorox had a return on equity of 538.72% and a net margin of 11.40%. Clorox's quarterly revenue was up 4.5% on a year-over-year basis. During the same period last year, the business posted $1.82 EPS. Equities analysts forecast that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th will be issued a dividend of $1.24 per share. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date is Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a yield of 4.0%. Clorox's payout ratio is currently 76.07%.

Insider Buying and Selling

In related news, Director Pierre R. Breber bought 4,000 shares of the stock in a transaction on Wednesday, May 7th. The shares were purchased at an average price of $136.57 per share, for a total transaction of $546,280.00. Following the acquisition, the director owned 4,000 shares in the company, valued at $546,280. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Company insiders own 0.57% of the company's stock.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Further Reading

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: All Signs Point to More Growth Ahead
3 Quiet Growth Stocks With Major Momentum
The Market’s Next Big Winners? Start Here

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines